Skip to main content
Equibles

Knoll Capital Management, LLC

Position in PHAR — Pharming Group N.V.

CIK 1325083 MIAMI, FL
Back to PHAR Full portfolio

Position in PHAR

as of Jun 30, 2026 · filed Sep 10, 2026
Position Value
$56,823
-$10,685 QoQ
Shares Held
4,091
+0.8% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#7
of 17 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PHAR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Knoll Capital Management, LLC holds $72,284,754 across 10 Biotechnology names. PHAR ranks #10 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MGTX
MeiraGTx Holdings plc
 1,250,000 $16,887,500
2 ALDX
Aldeyra Therapeutics, Inc.
 5,475,516 $11,662,849
3 OCUL
Ocular Therapeutix, Inc
 1,150,400 $11,296,928
4 ENTX
Entera Bio Ltd.
 5,881,879 $10,410,925
5 NUVB
Nuvation Bio Inc.
 1,598,591 $9,079,996
6 ELTX
Elicio Therapeutics, Inc.
 1,211,957 $4,738,751
7 ABVX
Abivax S.A.
 35,000 $4,664,100
8 ABEO
Abeona Therapeutics Inc.
 485,515 $3,000,482

All Filings in PHAR

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $56,823 4,091
2026-03-31 $67,508 4,057